{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:48:16Z","timestamp":1787028496691,"version":"build-2736575974"},"reference-count":156,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Celiac disease (CD) is an immune-mediated systemic disorder elicited by the ingestion of gluten whose clinical presentation ranges from the asymptomatic form to clinical patterns characterized by multiple systemic involvement. Although CD is a disease more frequently diagnosed in patients with symptoms of malabsorption such as diarrhea, steatorrhea, weight loss, or failure to thrive, the raised rate of overweight and obesity among general pediatric and adult populations has increased the possibility to diagnose celiac disease in obese patients as well. Consequently, it is not difficult to also find obesity-related disorders in patients with CD, including \u201cmetabolic associated fatty liver disease\u201d (MAFLD). The exact mechanisms linking these two conditions are not yet known. The going assumption is that a gluten-free diet (GFD) plays a pivotal role in determining an altered metabolic profile because of the elevated content of sugars, proteins, saturated fats, and complex carbohydrates, and the higher glycemic index of gluten-free products than gluten-contained foods, predisposing individuals to the development of insulin resistance. However, recent evidence supports the hypothesis that alterations in one of the components of the so-called \u201cgut\u2013liver axis\u201d might contribute to the increased afflux of toxic substances to the liver triggering the liver fat accumulation and to the subsequent hepatocellular damage. The aim of this paper was to describe the actual knowledge about the factors implicated in the pathogenesis of hepatic steatosis in pediatric patients with CD. The presented review allows us to conclude that the serological evaluations for CD with anti-transglutaminase antibodies, should be a part of the general workup in the asymptomatic patients with \u201cnon-alcoholic fatty liver disease\u201d (NAFLD) when metabolic risk factors are not evident, and in the patients with steatohepatitis when other causes of liver disease are excluded.<\/jats:p>","DOI":"10.3390\/ijms24021764","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T03:40:34Z","timestamp":1673840434000},"page":"1764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["MAFLD and Celiac Disease in Children"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-925X","authenticated-orcid":false,"given":"Serena","family":"Scapaticci","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Chieti \u2018G. d\u2019Annunzio\u2019, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Venanzi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Chieti \u2018G. d\u2019Annunzio\u2019, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Chieti \u2018G. d\u2019Annunzio\u2019, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-2744","authenticated-orcid":false,"given":"Cosimo","family":"Giannini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Chieti \u2018G. d\u2019Annunzio\u2019, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: Prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MPG.0000000000003015","article-title":"Clinical Presentation in Children With Coeliac Disease in Central Europe","volume":"72","author":"Riznik","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Volta","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20587384211008709","DOI":"10.1177\/20587384211008709","article-title":"Celiac disease: Understandings in diagnostic, nutritional, and medicinal aspects","volume":"35","author":"Admou","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ejcn.2010.161","article-title":"Celiac disease and obesity: Need for nutritional follow-up after diagnosis","volume":"64","author":"Valletta","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.3748\/wjg.v19.i34.5658","article-title":"Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets","volume":"19","author":"Norsa","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: An international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hoffmanov\u00e1, I., S\u00e1nchez, D., Tu\u010dkov\u00e1, L., and Tlaskalov\u00e1-Hogenov\u00e1, H. (2018). Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications. Nutrients, 10.","DOI":"10.3390\/nu10070892"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Le Garf, S., N\u00e8gre, V., Anty, R., and Gual, P. (2021). Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121915"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","article-title":"Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive","volume":"28","author":"Wieckowska","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2016.03.009","article-title":"Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease","volume":"150","author":"Nobili","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1604371","DOI":"10.3389\/ijph.2021.1604371","article-title":"Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis","volume":"66","author":"Liu","year":"2021","journal-title":"Int. J. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12020-012-9731-y","article-title":"A pathogenetic link between non-alcoholic fatty liver disease and celiac disease","volume":"43","author":"Abenavoli","year":"2013","journal-title":"Endocrine"},{"key":"ref_18","first-page":"63","article-title":"Celiac disease and risk of liver disease: A general population-based study","volume":"5","author":"Ludvigsson","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jhep.2015.01.013","article-title":"Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease","volume":"62","author":"Reilly","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MPG.0000000000001216","article-title":"NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten-related Disorders","volume":"63","author":"Hill","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1542\/peds.2020-009829","article-title":"Alternative Etiologies of Liver Disease in Children With Suspected NAFLD","volume":"147","author":"Yodoshi","year":"2021","journal-title":"Pediatrics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents\u2014An IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr. Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/CEG.S7556","article-title":"Hepatic manifestations of celiac disease","volume":"3","author":"Freeman","year":"2010","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2009.04085.x","article-title":"Calreticulin is a B cell molecular target in some gastrointestinal malignancies","volume":"160","author":"Benes","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0896-8411(03)00137-9","article-title":"Epitopes of calreticulin recognised by IgA autoantibodies from patients with hepatic and coeliac disease","volume":"21","author":"Mothes","year":"2003","journal-title":"J. Autoimmun."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., and Lekic, N. (2019). Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020395"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","article-title":"The gut microbiota\u2014Masters of host development and physiology","volume":"11","author":"Sommer","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cmet.2020.09.004","article-title":"The Gut Microbiota at the Service of Immunometabolism","volume":"32","author":"Michaudel","year":"2020","journal-title":"Cell Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"Shanahan","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1872-034X.2012.01088.x","article-title":"Role of gut microbiota in liver diseases","volume":"43","author":"Miyake","year":"2013","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2174\/138161209788168164","article-title":"The role of the gut microbiota in energy metabolism and metabolic disease","volume":"15","author":"Cani","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fmed.2017.00137","article-title":"New Insights into the Pathogenesis of Celiac Disease","volume":"4","author":"Magris","year":"2017","journal-title":"Front. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"ref_39","first-page":"537","article-title":"Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2","volume":"64","year":"2015","journal-title":"Physiol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00042737-199903000-00012","article-title":"Prevalence and clinical importance of hypertransaminasaemia in coeliac disease","volume":"11","author":"Novacek","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2012.06538.x","article-title":"Zonulin, regulation of tight junctions, and autoimmune diseases","volume":"1258","author":"Fasano","year":"2012","journal-title":"Ann. N. Y. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2012.00213","article-title":"The role of chemokines in acute liver injury","volume":"3","author":"Saiman","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/bit.26370","article-title":"Integrated gut\/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk","volume":"114","author":"Chen","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.bbadis.2015.06.001","article-title":"Gliadin-mediated production of polyamines by RAW264.7 macrophages modulates intestinal epithelial permeability in vitro","volume":"1852","author":"Barilli","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10875-006-9061-z","article-title":"Gliadin peptides activate blood monocytes from patients with celiac disease","volume":"27","author":"Cinova","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jnutbio.2017.10.017","article-title":"Gluten peptides drive healthy and celiac monocytes toward an M2-like polarization","volume":"54","author":"Barilli","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_47","first-page":"1068","article-title":"The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors","volume":"19","author":"Lopetuso","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2362.2011.02609.x","article-title":"Altered intestinal tight junctions\u2019 expression in patients with liver cirrhosis: A pathogenetic mechanism of intestinal hyperpermeability","volume":"42","author":"Assimakopoulos","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver Macrophages: Old Dogmas and New Insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20160334","article-title":"Identification and treatment of the Staphylococcus aureus reservoir in vivo","volume":"213","author":"Surewaard","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7570\/jomes.2017.26.2.86","article-title":"The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease","volume":"26","author":"Miura","year":"2017","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/he.2000.5634","article-title":"Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4","volume":"31","author":"Su","year":"2000","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2006.12.190","article-title":"Attenuation of obesity-induced adipose tissue inflammation in C3H\/HeJ mice carrying a Toll-like receptor 4 mutation","volume":"354","author":"Suganami","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-016-0005-6","article-title":"Roles of hepatic stellate cells in liver inflammation: A new perspective","volume":"36","author":"Fujita","year":"2016","journal-title":"Inflamm. Regen."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrgastro.2015.90","article-title":"Novel players in coeliac disease pathogenesis: Role of the gut microbiota","volume":"12","author":"Verdu","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/apt.14397","article-title":"Review article: The gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease","volume":"47","author":"Woodhouse","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cmet.2015.03.001","article-title":"Regulation of obesity-related insulin resistance with gut anti-inflammatory agents","volume":"21","author":"Luck","year":"2015","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2017.11.004","article-title":"Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration","volume":"23","author":"Schroeder","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3920\/BM2012.0046","article-title":"Postbiotics: What else?","volume":"4","author":"Tsilingiri","year":"2013","journal-title":"Benef. Microbes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2018_314","article-title":"Can Postbiotics Represent a New Strategy for NEC?","volume":"1125","author":"Mosca","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1874091X01004010053","article-title":"The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects","volume":"4","author":"Abdulamir","year":"2010","journal-title":"Open Biochem. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbj.2016.04.004","article-title":"Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer","volume":"1","author":"Martel","year":"2016","journal-title":"Porto. Biomed. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1203\/PDR.0b013e318181b7fa","article-title":"Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants","volume":"64","author":"Mohan","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/gut.34.9.1215","article-title":"Colonic dysfunction in acute diarrhoea: The role of luminal short chain fatty acids","volume":"34","author":"Ramakrishna","year":"1993","journal-title":"Gut"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0959-8049(95)00165-F","article-title":"Role of short-chain fatty acids in the prevention of colorectal cancer","volume":"31","author":"Scheppach","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Farup, P.G., Rudi, K., and Hestad, K. (2016). Faecal short-chain fatty acids\u2014A diagnostic biomarker for irritable bowel syndrome?. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0446-z"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3748\/wjg.v25.i36.5543","article-title":"Evaluation and comparison of short chain fatty acids composition in gut diseases","volume":"25","author":"Niccolai","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.clnu.2010.04.002","article-title":"Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission","volume":"29","author":"Hamer","year":"2010","journal-title":"Clin. Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-407672-3.00003-4","article-title":"Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids","volume":"85","author":"Sun","year":"2013","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3389\/fmicb.2018.01995","article-title":"Role of Short Chain Fatty Acids in Controlling T(regs) and Immunopathology During Mucosal Infection","volume":"9","author":"Bhaskaran","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12275-018-7565-x","article-title":"Type 3 regulatory T cells at the interface of symbiosis","volume":"56","author":"Park","year":"2018","journal-title":"J. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic Immunity and the Microbiota","volume":"46","author":"Belkaid","year":"2017","journal-title":"Immunity"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1017\/S0007114513003607","article-title":"Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials","volume":"111","author":"Kellow","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1203\/01.pdr.0000250014.92242.f3","article-title":"Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier","volume":"61","author":"Peng","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/gast.1997.v112.pm9041241","article-title":"Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats","volume":"112","author":"Tappenden","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1018819032620","article-title":"Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes","volume":"43","author":"Tappenden","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0148607104028004210","article-title":"Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets","volume":"28","author":"Bartholome","year":"2004","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ajcn\/68.1.118","article-title":"Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats","volume":"68","author":"Tappenden","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2005.00313.x","article-title":"Gut microflora associated characteristics in children with celiac disease","volume":"100","author":"Stenhammar","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_94","first-page":"20905","article-title":"Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one year\u2019s gluten-free diet","volume":"24","author":"Stenhammar","year":"2013","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"Cavalieri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004836-198604000-00015","article-title":"Obesity in celiac sprue","volume":"8","author":"Semeraro","year":"1986","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_100","first-page":"226","article-title":"Obesity in an 18-year-old boy with untreated celiac disease","volume":"32","author":"Syrenicz","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_101","first-page":"329","article-title":"Atypical celiac disease presenting as obesity-related liver dysfunction","volume":"33","author":"Franzese","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1651-2227.2006.tb02292.x","article-title":"A boy with coeliac disease and obesity","volume":"95","author":"Oso","year":"2006","journal-title":"Acta Paediatr. (Oslo Nor. 1992)"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1440-1754.2009.01512.x","article-title":"The changing face of celiac disease: A girl with obesity and celiac disease","volume":"45","author":"Arslan","year":"2009","journal-title":"J. Paediatr. Child Health"},{"key":"ref_104","first-page":"314","article-title":"Obesity in adolescents with celiac disease: Two adolescents and two different presentations","volume":"53","author":"Balamtekin","year":"2011","journal-title":"Turk. J. Pediatr."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12986-018-0241-7","article-title":"Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice","volume":"15","author":"Lindquist","year":"2018","journal-title":"Nutr. Metab. (Lond.)"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/1319-3767.195554","article-title":"Gluten-Free hepatomiracle in \u201cceliac hepatitis\u201d: A case highlighting the rare occurrence of nutrition-induced near total reversal of advanced steatohepatitis and cirrhosis","volume":"22","author":"Gaur","year":"2016","journal-title":"Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jgh.13704","article-title":"Coeliac disease in the 21st century: Paradigm shifts in the modern age","volume":"32","author":"Newnham","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","article-title":"Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC","volume":"11","author":"Sydor","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_109","first-page":"2646","article-title":"Anti-TNF\u03b1 treatment in Crohn\u2019s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status","volume":"41","author":"Manka","year":"2021","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Manka, P., Sydor, S., Sch\u00e4nzer-Ocklenburg, J.M., Brandenburg, M., Best, J., Vilchez-Vargas, R., Link, A., Heider, D., Brodesser, S., and Figge, A. (2022). A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver. Metabolites, 12.","DOI":"10.3390\/metabo12020130"},{"key":"ref_112","first-page":"443","article-title":"Serum primary bile acids in the course of celiac disease in children","volume":"14","author":"Ejderhamn","year":"1992","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0016-5085(19)33344-X","article-title":"Impaired cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue","volume":"63","author":"DiMagno","year":"1972","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.14.3.204","article-title":"The effect of coeliac disease upon bile salts","volume":"14","author":"Heaton","year":"1973","journal-title":"Gut"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0016-5085(85)90497-4","article-title":"Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet","volume":"88","author":"Maton","year":"1985","journal-title":"Gastroenterology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/nmo.12094","article-title":"Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: Cholecystitis is not caused by cystic duct obstruction","volume":"25","author":"Behar","year":"2013","journal-title":"Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.mehy.2005.05.013","article-title":"Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease?","volume":"65","author":"Schmulson","year":"2005","journal-title":"Med. Hypotheses"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20021234","article-title":"Transglutaminases: Nature\u2019s biological glues","volume":"368","author":"Griffin","year":"2002","journal-title":"Biochem. J."},{"key":"ref_119","first-page":"541","article-title":"Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver","volume":"41","author":"Elli","year":"2009","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.3748\/wjg.v18.i43.6255","article-title":"Celiac disease markers in patients with liver diseases: A single center large scale screening study","volume":"18","author":"Drastich","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gut.51.2.177","article-title":"Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ","volume":"51","author":"Esposito","year":"2002","journal-title":"Gut"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"308","DOI":"10.55095\/achot2015\/048","article-title":"Bone and Joint Involvement in Celiac Disease","volume":"82","year":"2015","journal-title":"Acta Chir. Orthop. Et Traumatol. Cechoslov."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00281-017-0659-4","article-title":"Dietary and metabolic modulators of hepatic immunity","volume":"40","author":"Carambia","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"603654","DOI":"10.3389\/fped.2020.603654","article-title":"New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease","volume":"8","author":"Lin","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: New genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Tortora, R., Rispo, A., Alisi, A., Imperatore, N., Crudele, A., Ferretti, F., Nobili, V., Miele, L., Gerbino, N., and Caporaso, N. (2018). PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease. Nutrients, 10.","DOI":"10.3390\/nu10091239"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/apt.13232","article-title":"Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages","volume":"42","author":"Mangge","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","article-title":"PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome","volume":"39","author":"Shen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejim.2014.05.012","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants","volume":"25","author":"Polimeni","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"ref_133","first-page":"788","article-title":"Metabolic-associated fatty liver disease (MAFLD) in coeliac disease","volume":"41","author":"Rispo","year":"2021","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/MPG.0b013e3182276d5e","article-title":"Celiac disease in normal-weight and overweight children: Clinical features and growth outcomes following a gluten-free diet","volume":"53","author":"Reilly","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5409\/wjcp.v6.i3.143","article-title":"Cardiometabolic risk factors in children with celiac disease on a gluten-free diet","volume":"6","author":"Anania","year":"2017","journal-title":"World J. Clin. Pediatr."},{"key":"ref_136","first-page":"810","article-title":"Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients","volume":"45","author":"Zanini","year":"2013","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.amjmed.2005.12.025","article-title":"Change in lipid profile in celiac disease: Beneficial effect of gluten-free diet","volume":"119","author":"Brar","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3945\/ajcn.2010.29786","article-title":"Global prevalence and trends of overweight and obesity among preschool children","volume":"92","author":"Borghi","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ajcn\/72.1.71","article-title":"Body composition in children with celiac disease and the effects of a gluten-free diet: A prospective case-control study","volume":"72","author":"Barera","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MCG.0b013e3181b7ed58","article-title":"Body mass index in celiac disease: Beneficial effect of a gluten-free diet","volume":"44","author":"Cheng","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2298\/SARH0912632R","article-title":"Effect of gluten-free diet on the growth and nutritional status of children with coeliac disease","volume":"137","author":"Brdar","year":"2009","journal-title":"Srp. Arh. Za Celok. Lek."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.numecd.2011.10.002","article-title":"Changes of body mass index in celiac children on a gluten-free diet","volume":"23","author":"Brambilla","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.3390\/nu5114553","article-title":"Gluten-free diet in children: An approach to a nutritionally adequate and balanced diet","volume":"5","author":"Penagini","year":"2013","journal-title":"Nutrients"},{"key":"ref_144","first-page":"519","article-title":"The gluten-free diet: A nutritional risk factor for adolescents with celiac disease?","volume":"27","author":"Mariani","year":"1998","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/ajg.2010.152","article-title":"Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease","volume":"105","author":"Patton","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/apt.13062","article-title":"Metabolic syndrome in patients with coeliac disease on a gluten-free diet","volume":"41","author":"Tortora","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-8227(00)00247-3","article-title":"Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus","volume":"52","author":"Mishima","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_149","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine Netw."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.2009.183608","article-title":"Lysosomal accumulation of gliadin p31\u201343 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa","volume":"59","author":"Luciani","year":"2010","journal-title":"Gut"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bfgp\/elr008","article-title":"Genome-wide association studies and type 2 diabetes","volume":"10","author":"Wheeler","year":"2011","journal-title":"Brief. Funct. Genom."},{"key":"ref_152","first-page":"58","article-title":"Serum lipoprotein profile in children with celiac disease","volume":"11","author":"Rosenthal","year":"1990","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_153","first-page":"459","article-title":"Serum lipids in celiac children","volume":"12","author":"Ciampolini","year":"1991","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_154","first-page":"183","article-title":"Effects of a gluten-free diet on serum lipids and lipoprotein (a) levels in a group of patients with celiac disease","volume":"18","author":"Pillan","year":"1994","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MPG.0000000000000785","article-title":"Gluten-Free Diet and Lipid Profile in Children With Celiac Disease: Comparison With General Population Standards","volume":"61","author":"Forchielli","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Mendez-Sanchez, N., Cruz-Ramon, V.C., Ramirez-Perez, O.L., Hwang, J.P., Barranco-Fragoso, B., and Cordova-Gallardo, J. (2018). New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072034"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:07:10Z","timestamp":1760119630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":156,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021764"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021764","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]}}}